门静脉高压症动脉血管低反应分子机制研究进展
Development of research on mechanism of arterial low reaction molecule in portal hypertension
出处
《杭州医学高等专科学校学报》
2003年第5期248-250,262,共4页
Journal of Hangzhou Medical College
参考文献23
-
1[1]Benoit JN,Zimmerman B,Permen AJ,et al.Role of glucagon in splanchnic of chronic portal hypertension[J].Am J Physiol,1986,251:G674-677.
-
2[2]Fiorucci S,Antonelli E, Morelli A.Nitric oxide and portal hypertension:a nitric oxide-releasing derivative of ursodeoxycholic acid that selectively releases nitric oxide in the liver[J].Dig Liver Dis, 2003,35 Suppl 2:S61-69.
-
3[3]Schepke M,Heller J,Paschke S,et al.Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis:evidence for a receptor-specific mechanism[J].Hepatology,2001,34:884-888.
-
4[4]Islam MZ,Williams BC,Madhavan KK,et al.Selective alteration of agonist-mediated contraction in hepatic arteries isolated from patients with cirrhosis [J].Gastroenterology,2000,118:765-771.
-
5[5]Huang YT,Chang SP,Lin HC,et al.Inositol phosphate responses in portal veins from portal hypertensive rats: receptor and nonreceptor-mediated responses[J].J Hepatol,1997,26:376-381.
-
6[6]Jakobsen K,Mikkelsen EO, Nielsen MO. Studies on responses to potassium, noradrenaline, serotonin, histamine and prostaglandin F2 alpha, of isolated pudendal arteries from nonlactating goats[J].Comp Biochem Physiol C Pharmacol Toxicol Endocrinol,1994,109:167-172.
-
7[7]Hartleb M, Moreau R,Gaudin C,et al. Lack of vascular hyporesponsiveness to the L-type calcium channel activator,Bay K 8644, in rats with cirrhosis[J].J Hepatol,1995,22:202-207.
-
8[8]Neef M, Biecker E, Heller J, et al. Portal hypertension is associated with increased mRNA levels of vasopressor G- proteincoupled receptors in human hepatic arteries [J].Eur J Clin Invest, 2003,33:249-255.
-
9[9]Bomzon A,Huang YT.Vascular smooth muscle cell signaling in cinhosis and portal hypertension[J].Pharmacol Ther,2001 ,89:255-272.
-
10[10]Cahill PA,Redmond EM, Sitzmann JV.Endothelial dysfunction in cirrhosis and portal hypertension[J].Pharmacol Ther,2001,89:273-293.
